Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human PlasmaSarah Burke, Andrew K.L. Goey|Therapeutic Drug Monitoring|2023Cited by 9